Physician profile
Michael Cohen
NPI 1982875829
$2,175.24
in general payments reported to CMS, 2019-2025
37 companies · $55.63 in 2025
The $55.63 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $455 · 2021: $915 · 2022: $60.88 · 2024: $36.92 · 2025: $55.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $446.90 | 2019-2025 | Xtandi |
| Dendreon Pharmaceuticals LLC | $156.39 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $128.82 | 2019-2021 | |
| Pfizer INC. | $110.85 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $102.09 | 2020-2022 | |
| Abbvie INC. | $93.78 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $82.76 | 2020-2022 | |
| Axonics, INC. | $81.25 | 2020-2021 | |
| Coloplast Corp | $75.18 | 2019-2021 | |
| Procept Biorobotics Corporation | $75.13 | 2019 | |
| Amgen INC. | $73.63 | 2019-2022 | |
| Teleflex LLC | $66.63 | 2021-2025 | Deknatel |
| Merck Sharp & Dohme LLC | $59.27 | 2020-2021 | |
| Myovant Sciences INC. | $55.15 | 2021 | |
| Janssen Biotech, INC. | $54.44 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $54.33 | 2020-2021 | |
| Allergan, INC. | $53.25 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $46.88 | 2019-2021 | |
| Boston Scientific Corporation | $43.75 | 2019-2021 | |
| Antares Pharma, INC. | $29.14 | 2019 | |
| Blue Earth Diagnostics | $28.89 | 2019-2021 | |
| Urovant Sciences INC | $24.46 | 2021 | |
| Ethicon US, LLC | $23.50 | 2024 | Ethicon |
| 180 Medical, INC. | $18.84 | 2019 | |
| Medtronic USA, INC. | $17.93 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.65 | 2025 | |
| Ferring Pharmaceuticals INC. | $17.10 | 2020 | |
| Karl Storz Endoscopy-America | $15.88 | 2020 | |
| Neotract INC. | $15.13 | 2020 | |
| Foundation Medicine, INC. | $14.83 | 2020 | |
| Clarus Therapeutics INC. | $14.65 | 2021 | |
| Travere Therapeutics, INC. | $13.75 | 2019 | |
| Sagent Pharmaceuticals | $13.63 | 2021 | |
| Urogen Pharma, INC. | $13.42 | 2024 | |
| Palette Life Sciences, INC. | $13.39 | 2021 | |
| Olympus America INC. | $11.37 | 2021 | |
| Photocure INC | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.